Company Filing History:
6 out of 2,886 
4 out of 975 
Years Active: 1998-2021
Title: Colin Parrish: Innovator in Canine Influenza Vaccine Development
Introduction
Colin Parrish is a prominent inventor based in Ithaca, NY (US), known for his significant contributions to the field of veterinary medicine, particularly in the development of vaccines for canine influenza virus. With a total of 6 patents to his name, Parrish has made strides in creating innovative solutions for the treatment and prevention of viral infections in dogs.
Latest Patents
Among his latest patents, one notable invention is the "Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus." This invention focuses on compositions and methods aimed at combating canine influenza virus (CIV) and related health issues. The innovation is based on the discovery that specific mutations in segments 1 and 2 of the CIV genome, which encode mutant PB2 and PB1 proteins, can render the virus temperature-sensitive.
Another significant patent is the "NS1 truncated virus for the development of canine influenza vaccines." This invention also targets the treatment and prevention of CIV and related conditions. It involves the development of a mutant CIV with one or more mutations in segment 8, which is designed to induce a CIV-specific immune response in affected subjects.
Career Highlights
Colin Parrish has had a distinguished career, working with esteemed institutions such as the University of Rochester and Cornell University. His work has been pivotal in advancing the understanding and treatment of canine influenza, showcasing his dedication to veterinary science and public health.
Collaborations
Throughout his career, Parrish has collaborated with notable colleagues, including Luis Martinez-Sobrido and Aitor Nogales-Gonzalez. These partnerships have contributed to the success of his research and the development of effective vaccines.
Conclusion
Colin Parrish's innovative work in the field of canine influenza vaccine development has made a significant impact on veterinary medicine. His patents reflect a commitment to improving animal health and preventing viral infections in dogs.